Wound healing in adult skin: Aiming for perfect regeneration

International Journal of Dermatology

Volumn 50, Issue 9, 2011, Pages 1058-1066

  Heng, Madalene C Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CURCUMIN; FLUOROURACIL; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 4; SILICONE GEL; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

ADULT; BASAL CELL CARCINOMA; BLOOD VESSEL INJURY; BONE CANCER; CORTICOSTEROID THERAPY; CYTOKINE PRODUCTION; EYELID CARCINOMA; HUMAN; HYPERBARIC OXYGEN; HYPERTROPHIC SCAR; INTRACELLULAR SIGNALING; KELOID; LOW LEVEL LASER THERAPY; NONHUMAN; NOSE CARCINOMA; PULSED DYE LASER; REVIEW; SCAR FORMATION; SKIN INJURY; SKIN SCAR; TISSUE REGENERATION; WOUND DRESSING; WOUND HEALING;

ADULT; AGED; AGED, 80 AND OVER; CICATRIX; FEMALE; HUMANS; KELOID; MALE; REGENERATION; SIGNAL TRANSDUCTION; SKIN PHYSIOLOGICAL PHENOMENA; WOUND HEALING;

EID: 80051903066     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2011.04940.x     Document Type: Review

References (42)

1. Martin P. Wound healing - aiming for perfect skin regeneration. Science 1997; 276: 75-81.
2. Springer TA. Traffic signal for lymphocyte recirculation and lymphocyte emigration: the multistep paradigm. Cell 1994; 76: 301-314.
3. Leibovich SJ, Ross R. The role of the macrophage in wound repair. Am J Pathol 1975; 78: 71-100.
4. Desmoulière A, Gabbiani G. The Molecular and Cellular Biology of Wound Repair. New York, NY: Plenum, 1996: 391-423.
5. Desmoulière A, Geinoz A, Gabbiani F, et al. Transforming growth factor-beta 1 induces alpha smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103-111.
6. Grinnell F. Fibroblasts, myofibroblasts and wound contraction. J Cell Biol 1994; 124: 401-404.
7. Montesano R, Orci L. Transforming growth factor-beta stimulates collagen matrix contraction by fibroblasts; implication for wound healing. Proc Natl Acad Sci USA 1988; 85: 4894-4897.
8. Clark RA, Folkword JM, Hart CE, et al. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest 1989; 84: 1036-1040.
9. Abou AG, Maraee AH, Al-Bara AM, et al. Immunohistochemical expression of TGF-beta1 in keloids and hypertrophic scars. Am J Dermatopathol 2011; 33: 334-391.
10. Lee TY, Chin GS, Kim WJ, et al. Expression of transforming growth factor-beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 1999; 43: 179-184.
11. Tredget EE, Yang L, Delehanty M, et al. Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. J Interferon Cytokine Res 2006; 26: 179-189.
12. Dunkin CS, Pleat JM, Gillespie PH, et al. Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plast Reconstr Surg 2007; 119: 1722-1732.
13. Ali-Bahar M, Bauer B, Tredget EE, et al. Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA. Wound Repair Regen 2004; 12: 175-182.
14. Wang J, Dodd C, Shankowsky HA, et al. Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 2008; 88: 1278-1290.
15. Heng MC, Harker J, Csathy G, et al. Angiogenesis in necrotic ulcers treated with hyperbatic oxygen. Ostomy Wound Manage 2000; 46: 18-32.
16. Martin P, Lewis J. Actin cables and epidermal movement in embryonic wound healing. Nature 1992; 360: 179-183.
17. McCluskey J, Martin P. Analysis of the tissue movements of embryonic wound healing - DiI studies in the limb bud stage mouse embryo. Dev Biol 1995; 170: 102-114.
18. Estes JM, Vande Berg JS, Adzick NS, et al. Phenotypic and functional features of myofibroblasts in sheep fetal wounds. Differentiation 1994; 56: 173-181.
19. Armstrong JR, Fergusen MW. Ontogeny of the skin and transition from scar free to scarring phenotype during wound healing in the pouch young of a marsupial, Monodelphis domestica. Dev Biol 1995; 169: 242-260.
20. Adzick NS, Harrison MR, Glick PL, et al. Comparison of fetal, newborn, and adult wound healing by histologic, enzyme-histochemical, and hydroxyproline determinations. J Pediatr Surg 1985; 20: 315-319.
21. Whitby DJ, Fergusen MW. Immunohistochemical localization of growth factors in fetal wound healing. Dev Biol 1991; 147: 207-215.
22. Martin P, Dickson MC, Millan FA, et al. Rapid induction and clearance of TGF-beta 1 is an early response in wounding in mouse embryo. Dev Genet 1993; 14: 225-238.
23. Frank S, Madlener M, Werner S. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially regulated during normal and impaired wound healing. J Biol Chem 1996; 271: 10188-10193.
24. Heng MCY. Curcumin targeted signaling pathways: basis for anti-photoaging and anti-carcinogenic therapy. Int J Dermatol 2010; 49: 608-632.
25. Wang J, Chen H, Shankowsky HA, et al. Improved scar in post-burn patients following interferon-alpha2b treatment is associated with decreased angiogenesis mediated by vascular endothelial growth factor. J Interferon Cytokine Res 2008; 28: 423-434.
26. Fergusen MW, O'Kane S. Scar-free healing from embryonic mechanisms to adult therapeutic intervention. Philos Trans R Soc Lond B Biol Sci 2004; 359: 839-850.
27. Wang J, Jiao H, Stewart TL, et al. Improvement in postburn hypertrophic scar after treatment with interferon-α2b is associated with decreased fibrocytes. J Interferon Cytokine Res 2007; 27: 921-930.
28. Choe JH, Park YL, Kim BJ, et al. Prevention of thyroidectomy scar using a new 1, 550nm fractional erbium-glass laser. Dermatol Surg 2009; 35: 1199-1205.
29. Chan HH, Wong DS, Ho WS, et al. The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in Chinese persons. Dermatol Surg 2004; 30: 987-994.
30. Katz TM, Glaich AS, Goldberg LF, et al. 595-nm long pulsed laser and 1450-nm diode laser in combination with intralesional triamcinolone/5-fluorouracil for hypertrophic scarring following a phenol peel. J Am Acad Dermatol 2010; 62: 1045-1049.
31. O'Brien L, Pandit A. Silicon gel sheeting for preventing and treating hypertrophic and keloid scars. Cochrane Database Syst Rev 2006; 25: CD003826.
32. Aggarwal BB. Nuclear factor-kappa B: the enemy within. Cancer Cell 2004; 6: 203-208.
33. Verma IM, Stevenson JK, Schwarz EM, et al. Rel/NF-κB family: intimate tales of association and disassociation. Genes Dev 1995; 270: 2723-2735.
34. Takada Y, Singh S, Aggarwal BB. Identification of p65 peptide that selectively inhibits NF-kappa B activation induced by various inflammatory stimuli and its role in downregulation of NF-kappaB-mediated gene expression and upregulation of apoptosis. J Biol Chem 2004; 279: 15096-15104.
35. Lallena MJ, Diaz-Meco MT, Bren G, et al. Activation of IκBa by protein kinase C isoforms. Moll Cell Biol 1999; 19: 2180-2188.
36. cHuang WC, Chen JJ, Chen CC. c-Src dependent tyrosine phosphorylation of IKKbeta is involved in tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 expression. J Biol Chem 2003; 278: 9944-9952.
37. Yang F, Yamashita J, Tang E, et al. The zinc finger C417R of I-kappa B-kinase gamma impairs lipopolysaccharide and TNF-mediated NF-kappa B activation through inhibiting phosphorylation of the I-kappa B kinase beta activation loop. J Immunol 2004; 172: 2446-2452.
38. Reddy S, Aggarwal BB. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 1994; 341: 19-22.
39. Graves D, Bartelson C, Bjorn A, et al. Substrate and inhibitor recognition of protein kinases: what is known about the catalytic subunit of phosphorylase kinase? Pharmacol Ther 1999; 82: 143-155.
40. Yuan CJ, Huang CY, Graves DJ. Phosphorylase kinase: a metal ion dependent dual specificity kinase. J Biol Chem 1993; 268: 17683-17686.
41. Chen A, Zheng S. Curcumin inhibits connective tissue growth factor gene expression in activated hepatic stellate cells in vitro by blocking NF-kappa B and ERK signaling. Br J Pharmacol 2008; 153: 557-567.
42. Heng MC, Song MK, Harker J, et al. Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical histological and immunohistochemical parameters. Br J Dermatol 2000; 143: 937-949.